SCHEMBL319215

SCHEMBL319215

NC1C[N]CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9426579 0.71
SCHEMBL4624350 0.67
SCHEMBL8732331 0.67
SCHEMBL1861309 0.67
SCHEMBL2442385 0.67
SCHEMBL3831743 0.67
SCHEMBL492076 0.67
SCHEMBL1570026 0.67
SCHEMBL2038001 0.67
SCHEMBL1742345 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5109131-A METHOD FOR PRODUCTION OF T-BUTYL 3-OXOBUTYRATES AND THEIR USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-04-28 US claimed
US-4517361-A BACTERICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1985-05-14 US claimed
US-4421912-A BACTERICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1983-12-20 US claimed
CN-102414205-B Isoxazole-pyrazole derivatives HOFFMANN LA ROCHE 2014-11-05 CN disclosed
CN-102414208-B Isoxazole-thiazole derivatives as GABAA a receptor inverse agonists for use in the treatment of cognitive disorders HOFFMANN LA ROCHE 2014-11-05 CN disclosed
CN-102414206-B Isoxazole-pyridine derivatives HOFFMANN LA ROCHE 2014-11-05 CN disclosed
EP-2680842-A1 METHODS OF TREATING A DISEASE OR CONDITION OF THE CENTRAL NERVOUS SYSTEM Bionomics Limited (AU) 2014-01-08 EP disclosed
EP-1349914-B2 A PROCESS FOR THE PRODUCTION OF CLEANING AGENTS RECKITT BENCKISER NV (NL) 2013-09-04 EP disclosed
CN-103249728-A Novel triazole compounds III HOFFMANN LA ROCHE 2013-08-14 CN disclosed
CN-101646656-B Pyrimidine hydrazide compounds as PGDS inhibitors SANOFI AVENTIS SPA 2013-08-14 CN disclosed
CN-103221402-A Triazole derivatives and their use for neurological disorders HOFFMANN LA ROCHE 2013-07-24 CN disclosed
WO-2009106708-A2 AZETIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI-AVENTIS (FR) 2009-09-03 WO disclosed
WO-2008098058-A1 PI 3-KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS AG (CH) 2008-08-14 WO disclosed
CN-1906183-A N-acylsulfonamide apoptosis promoters ABBOTT LAB (US) 2007-01-31 CN disclosed
CN-1224427-A 6-O-substituted erythromycin compounds and preparation method thereof ABBOTT LAB (US) 1999-07-28 CN disclosed
US-5358949-A Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-25 US disclosed
US-5017724-A Antihypoxic, CNS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-05-21 US disclosed
EP-0267024-B1 HYDROFLUORENE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-05-02 EP disclosed
EP-0267024-A2 Hydrofluorene derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-05-11 EP disclosed
EP-0236140-A2 Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-09-09 EP disclosed